About me
Kelly Griffin, PhD, RAC currently leads the Health Policy and Intelligence Institute at PwC where she serves as a strategic advisor for the health sector with a US focus, global mindset. She is passionate about the impact of policies in development and implementation stages and believes in building an ecosystem which provides the highest quality products and services to patients who need them the most.
Kelly is a health policy leader with a deep understanding of key federal policy and regulatory challenges affecting life science and healthcare stakeholders. She has a strong interest in regulatory precedents and commercial implications of product development and regulatory strategies.
Previously, Kelly led the FDA Policy and Regulatory Strategy practice at Avalere Health in Washington DC where she served clients from across the heath sector in navigating an evolving regulatory landscape.
Kelly received her PhD in Bioanalytical Chemistry from Pittsburgh University where she studied the design and synthesis of peptide therapeutics.
